Terms: = Uterine cancer AND MYO5A, Q9Y4I1, MYR12, MYO5, MYH12, GS1, ENSG00000197535, 4644
3 results:
1. HER2 Status Assessment in Endometrial Serous Carcinoma: Comparative Analysis of Two Proposed Testing and Interpretation Algorithms.
Hashem S; Zare SY; Fadare O
Int J Gynecol Pathol; 2024 Jan; 43(1):4-14. PubMed ID: 37406350
[TBL] [Abstract] [Full Text] [Related]
2. Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis.
Barrington DA; Riedinger C; Haight PJ; Tubbs C; Cohn DE
Gynecol Oncol; 2022 Jun; 165(3):500-505. PubMed ID: 35422338
[TBL] [Abstract] [Full Text] [Related]
3. Expression of blood group antigens and lectin binding in adenocarcinomas of the endometrium.
Memon RS; Yonezawa S; Hasui K; Sato E
Acta Pathol Jpn; 1990 Jul; 40(7):509-16. PubMed ID: 2220398
[TBL] [Abstract] [Full Text] [Related]
